Skip to Content

Cafe Serendipity Holdings Inc CAFS

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CAFS is trading at a 60% discount.
Price
$0.00
Fair Value
$4.65
Uncertainty
Extreme
1-Star Price
$3.27
5-Star Price
$3.49
Economic Moat
Ymdq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CAFS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.06
Bid/Ask
$0.03 / $0.04
Market Cap
$541.77
Volume/Avg
4,000 / 2,337

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Cafe Serendipity Holdings Inc is a development stage company, offering a turn-key licensed retail solution for a chain of upscale licensed stores serving the recreational and medical marijuana consumer.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Total Number of Employees
1

Valuation

Metric
CAFS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
CAFS
Quick Ratio
0.01
Current Ratio
0.02
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
CAFS
Return on Assets (Normalized)
−82.62%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−467.04%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Sponsor Center